1. Home
  2. CCG vs KYNB Comparison

CCG vs KYNB Comparison

Compare CCG & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheche Group Inc.

CCG

Cheche Group Inc.

HOLD

Current Price

$17.11

Market Cap

30.8M

Sector

N/A

ML Signal

HOLD

KYNB

Kyntra Bio Inc. Common Stock

N/A

Current Price

$7.55

Market Cap

27.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCG
KYNB
Founded
2014
1993
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.8M
27.1M
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
CCG
KYNB
Price
$17.11
$7.55
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$350.00
N/A
AVG Volume (30 Days)
19.7K
7.9K
Earning Date
05-27-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
9552.08
EPS
N/A
N/A
Revenue
N/A
$6,440,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$567.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$6.32
52 Week High
$17.99
$9.58

Technical Indicators

Market Signals
Indicator
CCG
KYNB
Relative Strength Index (RSI) 67.30 58.76
Support Level $0.65 $6.61
Resistance Level N/A $7.41
Average True Range (ATR) 1.86 0.30
MACD -0.27 0.04
Stochastic Oscillator 70.38 77.02

Price Performance

Historical Comparison
CCG
KYNB

About CCG Cheche Group Inc.

Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services, and other services in China. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Share on Social Networks: